284 related articles for article (PubMed ID: 31878273)
21. Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer.
Blondel A; Benberghout A; Pedeux R; Ricordel C
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640185
[TBL] [Abstract][Full Text] [Related]
22. The return of the INGs, histone mark sensors and phospholipid signaling effectors.
Bua DJ; Binda O
Curr Drug Targets; 2009 May; 10(5):418-31. PubMed ID: 19442114
[TBL] [Abstract][Full Text] [Related]
23. ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma.
Li X; Kikuchi K; Takano Y
J Oncol; 2011; 2011():963614. PubMed ID: 21052543
[TBL] [Abstract][Full Text] [Related]
24. Biological functions of the ING family tumor suppressors.
Campos EI; Chin MY; Kuo WH; Li G
Cell Mol Life Sci; 2004 Oct; 61(19-20):2597-613. PubMed ID: 15526165
[TBL] [Abstract][Full Text] [Related]
25. Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.
McClurg UL; Nabbi A; Ricordel C; Korolchuk S; McCracken S; Heer R; Wilson L; Butler LM; Irving-Hooper BK; Pedeux R; Robson CN; Riabowol KT; Binda O
Br J Cancer; 2018 Mar; 118(5):713-726. PubMed ID: 29381681
[TBL] [Abstract][Full Text] [Related]
26. Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.
Ceruti JM; Ogara MF; Menéndez C; Palmero I; Cánepa ET
Mol Cell Biochem; 2013 Jun; 378(1-2):117-26. PubMed ID: 23459830
[TBL] [Abstract][Full Text] [Related]
27. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
28. The ING tumor suppressor genes: status in human tumors.
Guérillon C; Bigot N; Pedeux R
Cancer Lett; 2014 Apr; 345(1):1-16. PubMed ID: 24333729
[TBL] [Abstract][Full Text] [Related]
29. The inhibitor of growth (ING) gene family: potential role in cancer therapy.
Gunduz M; Gunduz E; Rivera RS; Nagatsuka H
Curr Cancer Drug Targets; 2008 Jun; 8(4):275-84. PubMed ID: 18537551
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
Cheung KJ; Mitchell D; Lin P; Li G
Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
[TBL] [Abstract][Full Text] [Related]
31. Potential usage of ING family members in cancer diagnostics and molecular therapy.
Gunduz M; Demircan K; Gunduz E; Katase N; Tamamura R; Nagatsuka H
Curr Drug Targets; 2009 May; 10(5):465-76. PubMed ID: 19442118
[TBL] [Abstract][Full Text] [Related]
32. ING proteins in cellular senescence.
Menéndez C; Abad M; Gómez-Cabello D; Moreno A; Palmero I
Curr Drug Targets; 2009 May; 10(5):406-17. PubMed ID: 19442113
[TBL] [Abstract][Full Text] [Related]
33. ING1a expression increases during replicative senescence and induces a senescent phenotype.
Soliman MA; Berardi P; Pastyryeva S; Bonnefin P; Feng X; Colina A; Young D; Riabowol K
Aging Cell; 2008 Dec; 7(6):783-94. PubMed ID: 18691180
[TBL] [Abstract][Full Text] [Related]
34. Signaling pathways of the ING proteins in apoptosis.
Shah S; Riabowol K
Curr Drug Targets; 2009 May; 10(5):385-91. PubMed ID: 19442111
[TBL] [Abstract][Full Text] [Related]
35. Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis.
Wang Y; Wang J; Li G
FEBS Lett; 2006 Jul; 580(16):3787-93. PubMed ID: 16782091
[TBL] [Abstract][Full Text] [Related]
36. Multiple variants of the ING1 and ING2 tumor suppressors are differentially expressed and thyroid hormone-responsive in Xenopus laevis.
Wagner MJ; Helbing CC
Gen Comp Endocrinol; 2005 Oct; 144(1):38-50. PubMed ID: 15955533
[TBL] [Abstract][Full Text] [Related]
37. The fellowships of the INGs.
Shi X; Gozani O
J Cell Biochem; 2005 Dec; 96(6):1127-36. PubMed ID: 16167330
[TBL] [Abstract][Full Text] [Related]
38. Regulation of repair pathway choice at two-ended DNA double-strand breaks.
Shibata A
Mutat Res; 2017 Oct; 803-805():51-55. PubMed ID: 28781144
[TBL] [Abstract][Full Text] [Related]
39. Keep-ING balance: tumor suppression by epigenetic regulation.
Tallen G; Riabowol K
FEBS Lett; 2014 Aug; 588(16):2728-42. PubMed ID: 24632289
[TBL] [Abstract][Full Text] [Related]
40. The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.
Goodarzi AA; Jeggo P; Lobrich M
DNA Repair (Amst); 2010 Dec; 9(12):1273-82. PubMed ID: 21036673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
